Screener
Innospec IOSP Performance Chemicals — Goodwill Impaired Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innospec in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The source filing: Innospec’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 12:12 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-056502
| (in millions) / At December 31, 2023 | Performance Chemicals | Fuel Specialties | Oilfield Services | Total |
|---|---|---|---|---|
| Gross cost | $146.9 | $207.6 | $44.8 | $399.3 |
| Accumulated impairment losses | — | — | — | — |
| Net book amount | $146.9 | $207.6 | $44.8 | $399.3 |
| Adjustment to the acquired fair values | (3.1) | — | — | (3.1) |
| Exchange effect | (13.7) | (0.1) | 0.1 | (13.7) |
| At December 31, 2024 | ||||
| Gross cost | $130.1 | $207.5 | $44.9 | $382.5 |
| Accumulated impairment losses | — | — | — | — |
Item 8 Financial Statements and Supplementary Data
FAQ
- What is Innospec's performance chemicals — goodwill impaired accumulated impairment loss?
- Innospec (IOSP) reported performance chemicals — goodwill impaired accumulated impairment loss of $0 in Q4 2025.
- What does performance chemicals — goodwill impaired accumulated impairment loss mean?
- This metric tracks the cumulative amount of impairment losses recognized against the goodwill of the Performance Chemicals segment. It indicates whether the value of acquired businesses has declined below their carrying amount due to adverse market conditions or underperformance. A growing balance suggests that previous acquisitions may not be delivering the expected economic benefits.
Ask your AI about Innospec's performance chemicals — goodwill impaired accumulated impairment loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude